Marinus Petrus De Baar

Title: Innovative Contributions of Marinus Petrus De Baar in Nucleic Acid Technology

Introduction

Marinus Petrus De Baar, an esteemed inventor from Utrecht, Netherlands, has made significant contributions to the field of nucleic acid technology. With a total of three patents to his name, he has demonstrated a commitment to improving diagnostics and detection methods in healthcare.

Latest Patents

One of his notable inventions is the "Mitochondrion-bound nucleic acid for determining a health status of an individual." This patent outlines means and methods for detecting mitochondrion-bound nucleic acid, with an emphasis on its application in diagnostics. The invention particularly focuses on preferable cell-free mitochondrion-bound nucleic acid, contributing to more accurate health assessments.

Another significant patent is titled "Storing and detecting nucleic acid administered to a solid carrier." This invention presents a method for detecting nucleic acid in various samples by administering a sample to a solid carrier that absorbs it. After drying the carrier, a representative portion is provided to a nucleic acid isolation solution, which facilitates the extraction and detection of nucleic acid. This method is particularly useful for stabilizing samples, such as body fluids, allowing them to be shipped efficiently to testing laboratories worldwide.

Career Highlights

Marinus has been affiliated with prominent companies, including Primagen Holding B.V. and UMC Utrecht Holding B.V. His work in these organizations has contributed significantly to advancements in molecular diagnostics and health technologies.

Collaborations

Throughout his career, Marinus has collaborated with notable colleagues, including Eveline Catherina A C Timmermans and Bob Van Gemen. These partnerships have enhanced his research and innovation capabilities, leading to groundbreaking developments in his field.

Conclusion

Marinus Petrus De Baar exemplifies the innovative spirit of inventors dedicated to improving healthcare through advanced technology. His patents not only reflect his expertise but also significantly contribute to the future of diagnostics and health monitoring. As the field of nucleic acid technology continues to evolve, the impact of his work is likely to resonate for years to come.